Systematic review of proton magnetic resonance spectroscopy of the striatum in parkinsonian syndromes

No abstract is available for this paper.

• Publication year

  2001

• Venue

  European Journal of Neurology

• Publication date

  2001-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1046/j.1468-1331.2001.00308.xPMID 11784341
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Systematic review of acute levodopa and apomorphine challenge tests in the diagnosis of idiopathic Parkinson's disease

  2000cited by this paper
• Basal ganglia metabolite concentrations in idiopathic Parkinson's disease and multiple system atrophy measured by proton magnetic resonance spectroscopy

  2000cited by this paper
• Progesterone metabolite and spontaneous myometrial contractions in vitro.

  1999cited by this paper
• Magnetic resonance imaging–based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy

  1999cited by this paper
• In vivo magnetic resonance spectroscopy of human fetal neural transplants

  1999cited by this paper
• Usefulness of proton magnetic resonance spectroscopy in differentiating parkinsonian syndromes

  1999influential reference
• Failure of the clonidine growth hormone stimulation test to differentiate multiple system atrophy from early or advanced idiopathic Parkinson's disease.

  1999cited by this paper
• Focal myoclonus associated with posterior thalamic hematoma

  1998cited by this paper
• Proton magnetic resonance spectroscopy in parkinson's disease and atypical parkinsonian disorders

  1997cited by this paper
• Proton magnetic resonance spectroscopy in steele‐richardson‐olszewski syndrome

  1997cited by this paper
• Unchanged basal ganglia N‐acetylaspartate and glutamate in idiopathic Parkinson's disease measured by proton magnetic resonance spectroscopy

  1997cited by this paper
• Proton magnetic resonance spectroscopic imaging in progressive supranuclear palsy, Parkinson's disease and corticobasal degeneration.

  1997cited by this paper
• Parkinsonism associated with acute intracranial hematomas: An [18F]dopa positron‐emission tomography study

  1997cited by this paper
• 5-30-04 Proton magnetic resonance spectroscopy in Parkinson's disease and atypical parkinsonian disorders

  1997cited by this paper
• Changes in putamen N-acetylaspartate and choline ratios in untreated and levodopa-treated Parkinson's disease: A proton magnetic resonance spectroscopy study

  1997cited by this paper
• Proton MR spectroscopic imaging of the striatum in Parkinson's disease.

  1997cited by this paper
• Advances in imaging Parkinson's disease.

  1997cited by this paper
• Amantadine‐induced “vocal” myoclonus

  1996cited by this paper
• Proton magnetic resonance spectroscopy of the striatum in Parkinson's disease patients with motor response fluctuations.

  1996cited by this paper
• Localized proton NMR spectroscopy in the striatum of patients with idiopathic Parkinson's disease: a multicenter pilot study.

  1995influential reference
• Differentiation of multiple system atrophy from idiopathic Parkinson's disease using proton magnetic resonance spectroscopy

  1995cited by this paper
• Accuracy of clinical diagnosis of idiopathic Parkinson's disease.

  1993cited by this paper
• Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

  1992cited by this paper
• Accuracy of Clinical Diagnosis in Parkinsonism — A Prospective Study

  1991cited by this paper

• Advanced Magnetic Resonance Imaging for Early Diagnosis and Monitoring of Movement Disorders

  2025cites this paper
• Quantification of short echo time MRS signals with improved version of QUantitation based on quantum ESTimation algorithm

  2023cites this paper
• Precision medicine to identify optimal diagnostic and therapeutic interventions for Parkinson's Disease

  2021cites this paper
• Current and Emerging MR Methods and Outcome in Rodent Models of Parkinson’s Disease: A Review

  2021cites this paper
• Pathophysiology of corticobasal degeneration: Insights from neurophysiological studies.

  2019cites this paper
• 5 Progressive Supranuclear Palsy

  2018cites this paper
• Physiological Effects of Nutritional Support in Patients with Parkinson ’ s Disease

  2018cites this paper
• Diagnosis of multiple system atrophy.

  2017cites this paper
• Juvenile myoclonic epilepsy Low back pain Lyme neuroborreliosis Monitoring hepatocellular carcinoma and liver cirrhosis development

  2017cites this paper
• Imaging Approaches to Cerebral Cortex Pathology

  2017cites this paper
• Role of Magnetic Resonance Imaging in the Diagnosis of Multiple System Atrophy

  2017cites this paper
• Magnetic resonance imaging for the diagnosis of Parkinson’s disease

  2017influential citation
• Proton MR Spectroscopy for Monitoring Pathologic Changes in the Substantia Nigra and Globus Pallidus in Parkinson Disease.

  2016cites this paper
• The Role of Functional Dopamine-Transporter SPECT Imaging in Parkinsonian Syndromes, Part 1

  2015cites this paper
• Brain energy metabolism in early MSA-P: A phosphorus and proton magnetic resonance spectroscopy study.

  2015cites this paper
• Functional magnetic resonance spectroscopic imaging of the mouse brain: overcoming current sensitivity limitations

  2015cites this paper
• Longitudinal follow-up and characterization of a robust rat model for Parkinson's disease based on overexpression of alpha-synuclein with adeno-associated viral vectors.

  2015cites this paper
• Subtle Alterations in Brain Anatomy May Change an Individual’s Personality in Chronic Pain

  2014cites this paper
• Quantification in magnetic resonance spectroscopy based on semi-parametric approaches

  2014cites this paper
• Progressive Supranuclear Palsy

  2014cites this paper
• Spectroscopie cérébrale par résonance magnétique : techniques et principales applications cliniques

  2014cites this paper
• Роль магнитно-резонансной спектроскопии в оценке когнитивных функций у пациентов с метаболическим синдромом

  2013cites this paper
• In Vivo Evidence of Increased nNOS Activity in Acute MPTP Neurotoxicity: A Functional Pharmacological MRI Study

  2013cites this paper
• Proton Magnetic Resonance Spectroscopy of the Central Nervous System

  2013cites this paper
• Neural metabolite changes in corpus striatum after rat multipotent mesenchymal stem cells transplanted in hemiparkinsonian rats by magnetic resonance spectroscopy

  2013cites this paper
• Investigation of the neuroprotective effects of bee-venom acupuncture in a mouse model of Parkinson’s disease by using immunohistochemistry and In-vivo1H magnetic resonance spectroscopy at 9.4 T

  2013cites this paper
• Brain Imaging in Behavioral Neuroscience

  2012cites this paper
• The neurochemical profile quantified by in vivo 1H NMR spectroscopy

  2012cites this paper
• Magnetic resonance imaging markers for early diagnosis of Parkinson's disease☆

  2012cites this paper
• Magnetic resonance imaging of the substantia nigra in Parkinson's disease

  2012cites this paper
• Elevated Serum C-Reactive Protein Relates to Increased Cerebral Myoinositol Levels in Middle-Aged Adults

  2012influential citation
• Proton Magnetic Resonance Spectroscopy (1H MRS): A Practical Guide for the Clinical Neuroscientist

  2011cites this paper
• Early Marker for the Diagnosis of Parkinson's Disease

  2011cites this paper
• Forelimb akinesia and metabolic alteration in the striatum following unilateral 6-hydroxydopamine lesion in rats: An in vivo proton magnetic resonance spectroscopy study

  2011cites this paper
• Demenzen und andere erworbene degenerative Erkrankungen

  2011cites this paper
• Assessment of metabolic changes in the striatum of a MPTP-intoxicated canine model: in vivo ¹H-MRS study of an animal model for Parkinson's disease.

  2011cites this paper
• Magnetic resonance spectroscopic methods for the assessment of metabolic functions in the diseased brain.

  2011cites this paper
• Advances in imaging in Parkinson's disease.

  2011cites this paper
• Mouse models in neurological disorders: applications of non-invasive imaging.

  2010cites this paper
• Brain magnetic resonance imaging techniques in the diagnosis of parkinsonian syndromes.

  2010cites this paper
• Basal ganglia cellular pathology in multiple system atrophy, progressive supranuclear palsy and Parkinson disease. Can quantitative magnetic resonance spectroscopic imaging make the difference?

  2010cites this paper
• Subclinical atherosclerosis is related to lower neuronal viability in middle-aged adults: a 1H MRS study.

  2010cites this paper
• Quantitative magnetic resonance spectroscopic imaging in Parkinson’s disease, progressive supranuclear palsy and multiple system atrophy

  2010cites this paper
• In Vivo Monitoring of Liposomal Encapsulated siRNA Delivery

  2010cites this paper
• Significance of MRI in Diagnosis and Differential Diagnosis of Parkinson’s Disease

  2010cites this paper
• Clinical MR Spectroscopy: Techniques and Applications

  2009cites this paper
• Assessment of metabolic changes in the striatum of a rat model of parkinsonism: an in vivo 1H MRS study

  2009cites this paper
• Potential of advanced MR imaging techniques in the differential diagnosis of parkinsonism

  2009cites this paper
• Proposed neuroimaging criteria for the diagnosis of multiple system atrophy

  2009cites this paper
• Role of Imaging Techniques in Discerning Neurobehavioral Changes in Ischemic, Neurodegenerative and Demyelinating Disorders

  2009cites this paper
• Influence of measured and simulated basis sets on metabolite concentration estimates

  2008cites this paper
• Metabolic changes detected by proton magnetic resonance spectroscopy in vivo and in vitro in a murin model of Parkinson’s disease, the MPTP‐intoxicated mouse

  2008cites this paper
• Studying neonatal bilirubin encephalopathy with conventional MRI, MRS, and DWI

  2008cites this paper
• Multinuclear Magnetic Resonance Spectroscopy for in Vivo Assessment of Mitochondrial Dysfunction in Parkinson's Disease

  2008cites this paper
• Progressive supranuclear palsy.

  2007cites this paper
• Magnetic resonance spectroscopic evidence for presupplementary motor area neuronal dysfunction in Parkinson's disease

  2007cites this paper
• MRI for the differential diagnosis of neurodegenerative parkinsonism in clinical practice.

  2007cites this paper
• MR Spectroscopy in Neurodegenerative Disease

  2007cites this paper
• Influences of dopaminergic treatment on motor cortex in Parkinson disease: A MRI/MRS study

  2007cites this paper
• Functional brain imaging: an evidence-based analysis.

  2006cites this paper
• Iconography : Estimation of metabolite concentrations of healthy mouse brain by magnetic resonance spectroscopy at 7 T

  2006cites this paper
• The diagnosis of Parkinson's disease.

  2006cites this paper
• Mesure de glutamate cérébral chez l'homme et le petit animal par spectroscopie RMN in vivo, application à la maladie de Parkinson

  2006influential citation
• Proton MRS of the unilateral substantia nigra in the human brain at 4 tesla: Detection of high GABA concentrations

  2006cites this paper
• Neurodegenerative Diseases: Progressive supranuclear palsy

  2005cites this paper
• Quantitative 1H Magnetic Resonance Spectroscopic Imaging Determines Therapeutic Immunization Efficacy in an Animal Model of Parkinson's Disease

  2005cites this paper
• An update on conventional and advanced magnetic resonance imaging techniques in the differential diagnosis of neurodegenerative parkinsonism

  2005cites this paper
• How to diagnose multiple system atrophy

  2005cites this paper
• Neurobiology of Disease Quantitative 1 H Magnetic Resonance Spectroscopic Imaging Determines Therapeutic Immunization Efficacy in an Animal Model of Parkinson ’ s Disease

  2005cites this paper
• How to diagnose MSA early: the role of magnetic resonance imaging

  2005cites this paper
• Magnetic Resonance Imaging and Magnetic Resonance Spectroscopy in Parkinson’s Disease

  2005cites this paper
• Time‐domain semi‐parametric estimation based on a metabolite basis set

  2005cites this paper
• Chemical shift magnetic resonance spectroscopy of cingulate grey matter in patients with minimal hepatic encephalopathy

  2005cites this paper
• Metabolite concentrations of healthy mouse brain by Magnetic Resonance Spectroscopy at 7 Tesla

  2005cites this paper
• Proton magnetic resonance neurospectroscopy and EEG cartography in corticobasal degeneration: correlations with neuropsychological signs

  2004cites this paper
• Cholinergic systems in progressive supranuclear palsy.

  2004cites this paper
• Multiple regional 1H-MR spectroscopy in multiple system atrophy: NAA/Cr reduction in pontine base as a valuable diagnostic marker.

  2004cites this paper
• Routine MRI for the differential diagnosis of Parkinson's disease, MSA, PSP, and CBD

  2003influential citation
• Use of functional imaging in parkinsonism and dementia

  2003cites this paper
• Progressive supranuclear palsy: where are we now?

  2002cites this paper
• Degenerative diseases Mild cognitive impairment: diagnosing Alzheimer's in the pre-dementia stage Related review: Mild cognitive impairment

  2002cites this paper
• Current awareness in NMR in biomedicine.

  2002cites this paper
• Semiparametric Estimation for Metabolomics

  2000cites this paper
• 비장 절제 위암 환자의 수술 전후의 T-림프구 아형 변화에 대한 연구

  1999cites this paper
• Magnetic Resonance Spectroscopy (mrs) Clinical Policy Bulletin: Magnetic Resonance Spectroscopy (mrs)

  year unknowncites this paper